Physician
Antonieta a Gimotea MD PA
Antonieta a Gimotea MD PA was paid $3.21M by Medicaid between Feb 2018 and Nov 2024, across 57 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.
33Billing provider infoANTONIETA A GIMOTEA MD PA
MISSION, TX 78572
MISSION, TX 78572
33aNPI1841324340assigned 03/15/2007
33bProvider typePediatrics Physician
28Total paid$3.21M
24GClaims135,207
24DCodes billed57
24AFirst – last monthFeb 2018 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#146 of 1,136
Median peer was paid$329K
This provider vs. median9.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39 | $862.75 | |
| 2019 | 310 | $6K | |
| 2020 | 8,950 | $177K | |
| 2021 | 31,806 | $764K | |
| 2022 | 41,153 | $972K | |
| 2023 | 30,441 | $742K | |
| 2024incomplete | 22,508 | $548K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 21,965 | 18,102 | $770K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 12% | 10,086 | 9,233 | $395K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 10% | 25,486 | 11,663 | $336K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 10% | 13,682 | 12,096 | $323K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.6% | 3,128 | 3,032 | $242K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.6% | 2,664 | 2,623 | $212K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.1% | 2,383 | 2,324 | $197K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 5.7% | 13,570 | 12,376 | $182K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.9% | 2,110 | 2,048 | $157K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.7% | 8,206 | 8,059 | $86K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.2% | 1,412 | 1,344 | $69K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.8% | 5,082 | 3,838 | $56K |
45 more codes
| 99429 | 1.7% | 1,693 | $55K | |
| 99000 | 1.1% | 3,623 | $35K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 669 | $26K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 270 | $21K |
| 90474 | <1% | 1,196 | $10K | |
| 87631 | <1% | 113 | $8K | |
| 99381 | <1% | 87 | $7K | |
| 92567 | <1% | 311 | $4K | |
| 97169 | <1% | 102 | $4K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 53 | $3K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 52 | $2K |
| 81002 | <1% | 728 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 151 | $1K |
| 81025 | <1% | 165 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 76 | $922.04 |
| 83014 | <1% | 168 | $778.80 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 20 | $700.20 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 31 | $431.44 |
| 87420 | <1% | 28 | $245.28 | |
| 90620 | <1% | 540 | $192.76 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 68 | $84.06 |
| 86580 | <1% | 13 | $77.52 | |
| 90686 | <1% | 3,958 | $38.47 | |
| 90651 | <1% | 976 | $0.48 | |
| 90671 | <1% | 552 | $0.30 | |
| 90715 | <1% | 512 | $0.15 | |
| 90707 | <1% | 261 | $0.03 | |
| 90696 | <1% | 117 | $0.01 | |
| 90648 | 0% | 1,003 | $0.00 | |
| 90700 | 0% | 192 | $0.00 | |
| 90734 | 0% | 598 | $0.00 | |
| 90670 | 0% | 1,249 | $0.00 | |
| 90633 | 0% | 793 | $0.00 | |
| 99051 | 0% | 56 | $0.00 | |
| 90710 | 0% | 90 | $0.00 | |
| 90716 | 0% | 202 | $0.00 | |
| 90619 | 0% | 81 | $0.00 | |
| 90697 | 0% | 410 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 2,092 | $0.00 |
| 90680 | 0% | 1,213 | $0.00 | |
| 90698 | 0% | 59 | $0.00 | |
| 90723 | 0% | 630 | $0.00 | |
| 36416 | 0% | 155 | $0.00 | |
| 90744 | 0% | 15 | $0.00 | |
| 90381 | 0% | 62 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGIMOTEA, ANTONIETA (PRESIDENT)